Argobio Studio

Igniter Europe

This venture studio develops therapeutics and technology platforms for oncology, autoimmune and rare diseases for the healthcare and pharmaceutical industries.

Curie.Bio

This company provides seed funding and drug discovery services for early-stage therapeutics founders to help them reach series A financing.

Astonishing Labs

This venture studio commercialises university research to build biotechnology companies developing therapies for various diseases to benefit patient populations.

Appia Bio

This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.

Mestag Therapeutics

This company develops antibody therapies targeting fibroblast immunology for patients with cancer and inflammatory diseases.

D3 Bio

This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.

Axcelius I/II

This company creation vehicle establishes and incubates biopharmaceutical firms developing treatments for cancer, rare diseases and neurodegenerative disorders.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.